|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4035 | |
| A61K 38/13 | |||
| A61K 45/06 | |||
| A61K 38/17 | |||
| A61K 39/395 | |||
| A61K 31/10 | |||
| A61K 31/165 | |||
| A61K 31/40 | |||
| A61K 31/4015 | |||
| A61K 31/519 |
| (11) | Number of the document | 2701701 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12719228.4 |
| Date of filing the European patent application | 2012-04-27 | |
| (97) | Date of publication of the European application | 2014-03-05 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/035359 |
| Date | 2012-04-27 |
| (87) | Number | WO 2012/149251 |
| Date | 2012-11-01 |
| (30) | Number | Date | Country code |
| 201161480263 P | 2011-04-28 | US |
| (72) |
SCHAFER, Peter, US
GANDHI, Anita, US
CAPONE, Lori, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | METHODS AND COMPOSITIONS USING PDE4 INHIBITORS FOR THE TREATMENT AND MANAGEMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES |
| METHODS AND COMPOSITIONS USING PDE4 INHIBITORS FOR THE TREATMENT AND MANAGEMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES |